PTC Therapeutics
PTCT
£41.88
Share price
-1.36%
Change (1 day)
81.77%
Change (1 year)
Categories
Operating Margin for PTC Therapeutics (PTCT)
Operating Margin as of March 2025 (TTM): -45.00%
According to PTC Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -45.00%. At the end of 2024 the company had an Operating Margin of -24.31%.
Operating Margin history for PTC Therapeutics from 2012 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -24.31% | -59.79% |
| 2023 | -60.45% | -14.94% |
| 2022 | -71.07% | -11.46% |
| 2021 | -80.27% | -11.81% |
| 2020 | -91.02% | 22.86% |
| 2019 | -74.09% | 69.73% |
| 2018 | -43.65% | 31.98% |
| 2017 | -33.07% | -79.29% |
| 2016 | -159.67% | -64.87% |
| 2015 | -454.58% | 15.44% |
| 2014 | -393.79% | 200.96% |
| 2013 | -130.85% | 40.47% |
| 2012 | -93.15% | -401.43% |
| 2011 | 30.90% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 2.25% | -105.00% | 🇺🇸 USA |
 | 13.71% | -130.47% | 🇺🇸 USA |
 | -1,434.51% | 3,087.80% | 🇺🇸 USA |
 | -2,957.72% | 6,472.71% | 🇺🇸 USA |
 | -190.23% | 322.73% | 🇺🇸 USA |
 | 26.37% | -158.60% | 🇨🇭 Switzerland |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.